Irish fund Fountain Healthcare leads €40m Dualyx fundraise
Belgian company hopes to break new ground in autoimmune disease treatments
Stay updated with breaking news from Wouter Verhoeven. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Belgian company hopes to break new ground in autoimmune disease treatments
Fountain Healthcare has co-led the Series A round of Dualyx, which is developing new ways to treat a wide range of autoimmune diseases.
Dualyx raises €40 million to progress Treg therapies for autoimmune diseases into the clinic Use of proceeds will enable the development of the Company's lead autoimmune program DT-001, targeting
EQS-News: Andera Partners / Key word(s): Financing Andera Partners co-leads a €40 million Series A of Dualyx, a Belgian biotech developing novel Treg therapies for autoimmune diseases 15.05.2023
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!